Repercussions resulted from chemoresistance acquisition such as Erk activation and the expressions of cyclins, and the regulation of the cell cycle could be pertinently modulated by manipulating the cellular AKR1B10 expression, underscoring its functional role in the progression of NSCLC. Here, AKR1B10 is linked to non-small cell lung carcinoma.